Article
Genetic contribution to mesenchymal stem cell dysfunction in systemic lupus erythematosus
24 May 2018
Abstract excerpt
Allogeneic mesenchymal stem cell (MSC) transplantation has recently become a promising therapy for patients with systemic lupus erythematosus (SLE). MSCs are a kind of multipotent stem cell than can efficiently modulate both innate and adaptive immune responses, yet those from SLE patients themselves fail to maintain the balance of immune cells, which is partly due to the abnormal genetic background. Clarifying...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
